An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)

NCT00109148 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: MK0364

Sponsor

Merck Sharp & Dohme LLC